Clinical trial Recruiting at 1 site Observational Ages 18 and up

Theta-burst rTMS to improve self-reported motor symptoms in functional neurological disorder

Official title: Impact of Theta Burst Repetitive Transcranial Magnetic Stimulation on the Patient's Self-reported Improvement in Their Motor Functional Neurological Disorder

Run by Hospital Center Guillaume Régnier · NCT07527403 · Data updated 2026-11-12

This project will try neuronavigated theta-burst repetitive transcranial magnetic stimulation (rTMS) to see if adults with motor functional neurological disorder feel their symptoms have improved.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment22 (estimated)
SponsorHospital Center Guillaume Régnier
Academic / other
Locations1 site (Rennes)
StatusRecruiting
StartedMarch 13, 2026
Main results expectedMarch 2028
Study endsMarch 2028
Registry record updatedApril 20, 2026
Trial IDNCT07527403 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) diagnosed with motor FND by a neurologist who are eligible for and agree to neuronavigated rTMS and can provide consent.

Probably not a fit

People under legal protection, those deprived of liberty, individuals with non-motor FND only, or those unable to undergo rTMS are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study using neuronavigated theta-burst rTMS targeted based on current neuroimaging models of motor FND, with a focus on the right temporo-parietal junction. The main outcome is the patient's own report of overall change in motor symptoms, with additional clinician-rated measures, quality-of-life scales, and assessments of mood and dissociation. Treatments are noninvasive magnetic stimulation sessions applied repeatedly to a specific brain region. The protocol follows recent recommendations for clinical evaluation in FND research and compares patient and clinician perspectives on symptom change.

Why it matters

Potential benefit: If successful, this approach could noninvasively reduce motor symptoms and improve daily functioning and quality of life for people with motor FND.

How similar studies have gone: Several smaller studies and case series have reported positive signals for rTMS in FND, but results have been mixed and targets and outcome measures have varied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over 18
* Patients with FND, either deficits or abnormal movements, diagnosed by a neurologist.
* Patients with an indication for validated neuronavigated rTMS treatment.
* Patients who have indicated that they do not object to participating in the study.

Exclusion Criteria:

* Patients subject to legal protection (legal guardianship, conservatorship, trusteeship)
* Patients deprived of liberty

Where it's running

  • Centre Hospitalier Guillaume Régnier
    Rennes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.